| Wilson Ching, MD | |
|
1740 W Taylor St, Chicago, IL 60612-7232 | |
| (866) 600-2273 | |
| Not Available |
| Full Name | Wilson Ching |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 7 Years |
| Location | 1740 W Taylor St, Chicago, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003349697 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | A170572 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Permanente Medical Group Inc | 8921910225 | 7800 |
News Archive
Regulators, manufacturers and academic researchers from around the world will convene for a two-day workshop on the scientific and regulatory challenges posed by the use of probiotic ingredients in food products. Discussions will focus on how public standards can assist in supporting transparency, consistency and competitiveness of ethical industry players as health claims surrounding probiotic products undergo increased scrutiny.
Hospira, the world's leading provider of injectable drugs and infusion technologies, today announced the European Commission (EC) approval of Inflectra™ (infliximab), Europe's first biosimilar monoclonal antibody (mAb) therapy. Inflectra has been approved for the treatment of inflammatory conditions including rheumatoid arthritis (RA), ankylosing spondylitis, Crohn's disease (CD), ulcerative colitis (UC), psoriatic arthritis (PsA) and psoriasis.
Although most people with bulimia and binge eating disorders wait many years before seeking help, a new review shows that psychological treatment can make a large difference — and that cognitive behavioral therapy (CBT) is the most effective talk therapy for these disorders.
A team of researchers from UCLA and Harvard University have demonstrated a technique that, by measuring the physical properties of individual cells in body fluids, can diagnose cancer with a high degree of accuracy.
OXIS International, Inc. announces the market launch of ErgoFlex™, a unique new dietary supplement for the relief of joint pain. It is the first in a series of commercial products planned by OXIS. ErgoFlex is the only joint health complex containing the powerful antioxidant Ergothioneine (ERGO), and is specifically formulated to help the body fight the pain of joint inflammation and maintain optimal joint health.
› Verified 5 days ago
| Entity Name | Permanente Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710 |
News Archive
Regulators, manufacturers and academic researchers from around the world will convene for a two-day workshop on the scientific and regulatory challenges posed by the use of probiotic ingredients in food products. Discussions will focus on how public standards can assist in supporting transparency, consistency and competitiveness of ethical industry players as health claims surrounding probiotic products undergo increased scrutiny.
Hospira, the world's leading provider of injectable drugs and infusion technologies, today announced the European Commission (EC) approval of Inflectra™ (infliximab), Europe's first biosimilar monoclonal antibody (mAb) therapy. Inflectra has been approved for the treatment of inflammatory conditions including rheumatoid arthritis (RA), ankylosing spondylitis, Crohn's disease (CD), ulcerative colitis (UC), psoriatic arthritis (PsA) and psoriasis.
Although most people with bulimia and binge eating disorders wait many years before seeking help, a new review shows that psychological treatment can make a large difference — and that cognitive behavioral therapy (CBT) is the most effective talk therapy for these disorders.
A team of researchers from UCLA and Harvard University have demonstrated a technique that, by measuring the physical properties of individual cells in body fluids, can diagnose cancer with a high degree of accuracy.
OXIS International, Inc. announces the market launch of ErgoFlex™, a unique new dietary supplement for the relief of joint pain. It is the first in a series of commercial products planned by OXIS. ErgoFlex is the only joint health complex containing the powerful antioxidant Ergothioneine (ERGO), and is specifically formulated to help the body fight the pain of joint inflammation and maintain optimal joint health.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Wilson Ching, MD 1919 W Taylor St, Chicago, IL 60612-7246 Ph: (510) 332-8023 | Wilson Ching, MD 1740 W Taylor St, Chicago, IL 60612-7232 Ph: (866) 600-2273 |
News Archive
Regulators, manufacturers and academic researchers from around the world will convene for a two-day workshop on the scientific and regulatory challenges posed by the use of probiotic ingredients in food products. Discussions will focus on how public standards can assist in supporting transparency, consistency and competitiveness of ethical industry players as health claims surrounding probiotic products undergo increased scrutiny.
Hospira, the world's leading provider of injectable drugs and infusion technologies, today announced the European Commission (EC) approval of Inflectra™ (infliximab), Europe's first biosimilar monoclonal antibody (mAb) therapy. Inflectra has been approved for the treatment of inflammatory conditions including rheumatoid arthritis (RA), ankylosing spondylitis, Crohn's disease (CD), ulcerative colitis (UC), psoriatic arthritis (PsA) and psoriasis.
Although most people with bulimia and binge eating disorders wait many years before seeking help, a new review shows that psychological treatment can make a large difference — and that cognitive behavioral therapy (CBT) is the most effective talk therapy for these disorders.
A team of researchers from UCLA and Harvard University have demonstrated a technique that, by measuring the physical properties of individual cells in body fluids, can diagnose cancer with a high degree of accuracy.
OXIS International, Inc. announces the market launch of ErgoFlex™, a unique new dietary supplement for the relief of joint pain. It is the first in a series of commercial products planned by OXIS. ErgoFlex is the only joint health complex containing the powerful antioxidant Ergothioneine (ERGO), and is specifically formulated to help the body fight the pain of joint inflammation and maintain optimal joint health.
› Verified 5 days ago
Dr. Ayesha Hussain, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 2424 W. Peterson Ave, Chicago, IL 60659 Phone: 773-761-0300 | |
Dr. Ernesto Estor, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3525 W Peterson Ave, Suite 210, Chicago, IL 60659 Phone: 773-293-6671 Fax: 773-961-8102 | |
Dr. Keri Leah Fair, M.D., PH.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4600 N Ravenswood Ave, 2nd Floor, Chicago, IL 60640 Phone: 773-561-7500 Fax: 773-561-7612 | |
Maximiliano Luna Jr., M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2001 S California Ave, Chicago, IL 60608 Phone: 773-584-6200 | |
Suyeun Ban, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1501 S California Ave Ste L1026, Chicago, IL 60608 Phone: 773-257-6097 | |
Dr. Gabrielle Denise Gay, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5425 W Lake St, Chicago, IL 60644 Phone: 773-378-3347 Fax: 773-378-4028 |